Drugbank Logo

Search Results

Search for "Cefotetan" returned 7 results

Showing 1-7 out of 7
DrugBank ID Name Formula Weight
DB01330
DrugCard button for DB01330
Cefotetan C17H17N7O8S4 575.6190
Cefotetan Cefotetan is a semisynthetic cephamycin antibiotic that is administered intravenously or intramuscularly. The drug is highly resistant to a broad spectrum of beta-lactamases and is ...
DB00274
DrugCard button for DB00274
Cefmetazole C15H17N7O5S3 471.5340
mirabilis</i>, but is less active than cefoxitin or cefotetan against most gram-negative bacilli. 42008 10303 APRD00852 Cefmetazole sodium Cefmetazolo [INN-Spanish] Cefmetazolum [INN-Latin] Oral ...
DB00479
DrugCard button for DB00479
Amikacin C22H43N5O13 585.6025
... of nephrotoxicity Cefotaxime Increased risk of nephrotoxicity Cefotetan Increased risk of nephrotoxicity Cefoxitin Increased risk of nephrotoxicity Cefradine Increased risk of nephrotoxicity ...
DB01032
DrugCard button for DB01032
Probenecid C13H19NO4S 285.3590
... level Cefotaxime Probenecid increases the antibiotic's level Cefotetan Probenecid increases the antibiotic's level Cefoxitin Probenecid increases the antibiotic's level Cefprozil Probenecid ...
DB00798
DrugCard button for DB00798
Gentamicin C21H43N5O7 477.5954
... of nephrotoxicity Cefotaxime Increased risk of nephrotoxicity Cefotetan Increased risk of nephrotoxicity Cefoxitin Increased risk of nephrotoxicity Cefradine Increased risk of nephrotoxicity ...
DB00955
DrugCard button for DB00955
Netilmicin C21H41N5O7 475.5795
... of nephrotoxicity Cefotaxime Increased risk of nephrotoxicity Cefotetan Increased risk of nephrotoxicity Cefoxitin Increased risk of nephrotoxicity Cefradine Increased risk of nephrotoxicity ...
DB00684
DrugCard button for DB00684
Tobramycin C18H37N5O9 467.5145
... of nephrotoxicity Cefotaxime Increased risk of nephrotoxicity Cefotetan Increased risk of nephrotoxicity Cefoxitin Increased risk of nephrotoxicity Cefradine Increased risk of nephrotoxicity ...
Showing 1-7 out of 7

This project is supported by Genome Alberta & Genome Canada, a not-for-profit organization that is leading Canada's national genomics strategy with $600 million in funding from the federal government. This project is also supported in part by GenomeQuest, Inc., an enterprise genomic information company serving the life science community.